摘要
Abstract
Interferon plus ribavirin is recommended for the treatment of hepatitis c.But the interferon plus ribavirin treatment for some patients is taboo.Interferon plus ribavirin treatment for genotype 1,previously treated,and for liver cirrhosis patients with poor effects,even some patients often stopped because of side effects.After 2011 years,the DAAs can achieve good curative effect in different genotypes,untreated,previously treated,cirrhosis of the live,and interferon contraindications HCV patients,even can achieve 100％ of SVR.The treatment of hepatitis C has good prospects.关键词
丙型病毒性肝炎/抗病毒/干扰素/直接抗病毒药物Key words
Hepatitis C/Antiviral/Interferon/Direct antiviral drugs
